Not cost-effective at zero price: valuing and paying for combination therapies in cancer.

Authors :: Latimer NR
Towse A
Henshall C
Source :: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2021 Jun; Vol. 21 (3), pp. 331-333. Date of Electronic Publication: 2021 Feb 09.
Publication Year :: 2021

Subjects :: Antineoplastic Combined Chemotherapy Protocols economics
Cost-Benefit Analysis
Drug Costs
Humans
Neoplasms economics
Technology Assessment, Biomedical
Antineoplastic Combined Chemotherapy Protocols administration & dosage
Neoplasms drug therapy

Full Text Access

Tools